Effect of TyG Index on Outcomes of Radical Prostatectomy

A Novel Prognostic Risk Factor for Patients Undergoing Radical Prostatectomy: Triglyseride-Glucose (TyG) Index

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03447028

Acronym

TyG-PCa

Enrollment

200

Registered

2018-02-27

Start date

2007-01-01

Completion date

2012-12-30

Last updated

2018-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Metabolic Syndrome, Prostate Cancer

Keywords

Triglyseride-Glucose index, prostate cancer, radical prostatectomy, metabolic syndrome

Brief summary

We investigate the association between Triglyserid-Glucose(TyG) index and prostate cancer in patients undergoing radical prostatectomy.

Detailed description

TyG index is calculated with special formula. Patients undergoing radical prostatectomy are divided two groups according to the cut-off level of 8.55 for TyG index.Groups were compared statistically in terms of oncological outcomes and survival.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

MALE

Healthy volunteers

Inclusion criteria

* Patients undergoing radical prostatectomy for prostate cancer

Exclusion criteria

* taking medicines for established diabetes and dyslipidaemia, * presence of endocrinological disease, * history of bariatric surgery, * missing data and patients with uncontrolled follow-up

Design outcomes

Primary

Measure	Time frame	Description
Oncological outcomes	5 years	Effect of TyG index on oncological outcomes of Prostate cancer

Secondary

Measure	Time frame	Description
Survival	5 years	Death date of patient after radical prostatectomy

Outcome results